1[5]Marks R. Trials and tribulations in psoriasis -a personal view [J]. J Dermatol Treat,1997,8:271.
2[6]Snellman E, Mal janen T, Aromaa A, et al.Effect of heliotherapy on the cost of psoriasis[J]. Br J Dermatol, 1998,138:288.
3[7]Dewe RS, Wainwright NJ, Cameron H, et al. Narrow- band (TL- 01) ultraviolet B phototherapy for chronic plaque psoriasis:three times of five times weekly treatment [J] ? Br J Dermatol, 1998,138: 833.
4[8]Kumor B, Kumor R, Kaur I,et al. Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle[J]? Int J Dermatol, 1997,36: 309.
5[9]Savolainen L, Kontinen J, Roning J, et al.Application of machine vision to assess involved surface in patients with psoriasis[J].Br J Dermatol, 1997,137:395.
6[10]Gonzalez S, Rajadhyaksha M, Anderson RR, et al. Non-invasive ( real-time )imaging of histologic margin of a proliferative skin Lesion in vivo[J]. J Invest Dermatol, 1998,111:538.
7[11]Mrowietz U, Christophers E, Altmeyer P,et al. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study[J]. Br J Dermatol, 1998,138:456.
8[12]Feldman SR, Fleischer AB, Reboussin DM,et al. The economic impact of psoriasis increases with psoriasis severity [J]. J Am Acad Dermatol, 1997,7: 564.
9[13]Faust HB,Gonin R,Chuang TY,et al. Reliability testing of the dermatology index of disease severity(DIDS)-an index for staging the severity of cutaneous in flammatory diseases [J]. Arch Dermatol,1997,133:1443.
10[14]Horrocks C,Duncan JI,Oliver AM,et al.Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A[J]. Clin Exp Immunol, 1991,84:157.
